Blockade of the ERK pathway markedly sensitizes tumor cells to HDAC inhibitor-induced cell death
- 27 January 2006
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 339 (4), 1171-1177
- https://doi.org/10.1016/j.bbrc.2005.11.131
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Targeting the mitogen-activated protein kinase cascade to treat cancerNature Reviews Cancer, 2004
- Histone Deacetylase InhibitorsAdvances in Cancer Research, 2004
- Selective Growth Inhibition of Tumor Cells by a Novel Histone Deacetylase Inhibitor, NVP-LAQ824Cancer Research, 2004
- Specific blockade of the ERK pathway inhibits the invasiveness of tumor cells: down-regulation of matrix metalloproteinase-3/-9/-14 and CD44Biochemical and Biophysical Research Communications, 2003
- Histone-deacetylase inhibitors: novel drugs for the treatment of cancerNature Reviews Drug Discovery, 2002
- Histone deacetylases and cancer: causes and therapiesNature Reviews Cancer, 2001
- Blockade of the Extracellular Signal-regulated Kinase Pathway Induces Marked G1 Cell Cycle Arrest and Apoptosis in Tumor Cells in Which the Pathway Is Constitutively ActivatedPublished by Elsevier BV ,2001
- Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumorsOncogene, 1999
- Signal Transduction through MAP Kinase CascadesAdvances in Cancer Research, 1998
- The MAPK signaling cascadeThe FASEB Journal, 1995